EAGLE PHARMACEUTICALS, INC. - COM (EGRX)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
9.86M
Holdings value Q2 2024
$55.2M
Value change Q2 2024
-$2.66M
Grand Portfolio weight change Q2 2024
0%
Number of holders
72
Number of buys Q2 2024
23
Number of sells Q2 2024
-67
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 9.86M $55.2M -$2.66M $5.60 73
2024 Q1 10.5M $54.8M +$2.17M $5.24 90
2023 Q4 10M $52.4M -$16.1M $5.23 101
2023 Q3 10.3M $163M -$8.5M $15.77 107
2023 Q2 10.8M $209M -$25.4M $19.44 121
2023 Q1 11.8M $334M +$6.2M $28.37 152
2022 Q4 11.6M $338M +$2.79M $29.23 153
2022 Q3 9.39M $248M -$7.96M $26.42 143
2022 Q2 11.6M $511M +$17.1M $44.43 157
2022 Q1 10.9M $542M +$1.17M $49.49 153
2021 Q4 10.9M $554M -$54.7M $50.92 155
2021 Q3 11.8M $659M -$12.5M $55.78 145
2021 Q2 11.9M $508M -$3.49M $42.80 137
2021 Q1 12.1M $505M -$2.4M $41.74 149
2020 Q4 12.2M $570M -$4.89M $46.57 159
2020 Q3 12.4M $526M -$21M $42.48 162
2020 Q2 12.9M $619M -$12.6M $47.98 158
2020 Q1 13.3M $611M -$9.92M $46.00 164
2019 Q4 13.1M $788M +$6M $60.08 174
2019 Q3 13.2M $745M -$18.9M $56.57 180
2019 Q2 13.5M $752M +$13M $55.68 176
2019 Q1 13.2M $669M -$19.8M $50.49 176
2018 Q4 13.9M $560M -$99M $40.29 177
2018 Q3 15.4M $1.07B -$755K $69.33 184
2018 Q2 15.3M $1.16B -$29.8M $75.66 177
2018 Q1 15.8M $832M -$8.71M $52.69 170
2017 Q4 16M $852M +$1.8M $53.42 164
2017 Q3 15.7M $938M +$8.01M $59.64 161
2017 Q2 15.3M $1.21B +$315M $78.89 169
2017 Q1 16.4M $1.36B +$96.1M $82.94 145
2016 Q4 16.5M $1.31B -$54.4M $79.34 147
2016 Q3 16.7M $1.17B +$53.7M $70.00 136
2016 Q2 17.2M $667M +$29.4M $38.79 114
2016 Q1 15.4M $625M -$9.3M $40.50 115
2015 Q4 14.9M $1.32B +$76.4M $88.67 133
2015 Q3 14.1M $1.04B +$47.2M $74.03 119
2015 Q2 13.4M $1.08B +$144M $80.86 119
2015 Q1 11.7M $489M +$142M $41.89 68
2014 Q4 9.2M $143M +$21.8M $15.50 28
2014 Q3 2.97M $37.6M +$13.8M $12.65 25
2014 Q2 1.74M $25M -$1.91M $14.33 28
2014 Q1 1.91M $24.4M +$24.4M $12.75 28